Abstract
The higher risk of osteoporosis and fracture associated with HIV infection and certain antiretrovirals has been well established and the need for risk stratification among older adults increasingly recognized. This review focuses upon emerging data on bone complications with HIV/HCV coinfection, in children and adolescents, and with pre-exposure prophylaxis (PrEP), as well as new management strategies to minimize the negative effects of ART on bone.
Original language | English (US) |
---|---|
Pages (from-to) | 349-358 |
Number of pages | 10 |
Journal | Current HIV/AIDS reports |
Volume | 13 |
Issue number | 6 |
DOIs | |
State | Published - Dec 1 2016 |
Keywords
- Bone
- Bone loss
- Bone mineral density
- Children and adolescents
- Fracture
- HIV/HCV coinfection
- Osteoporosis
- Peak bone mass
- PrEP
- Tenofovir
ASJC Scopus subject areas
- Infectious Diseases
- Virology